- Home
- TOVX vs ESE Comparison
TOVX vs ESE Comparison
Compare TOVX & ESE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOVX
- ESE
- Stock Information
- Founded
- TOVX 2001
- ESE 1990
- Country
- TOVX United States
- ESE United States
- Employees
- TOVX N/A
- ESE N/A
- Industry
- TOVX Biotechnology: Pharmaceutical Preparations
- ESE Telecommunications Equipment
- Sector
- TOVX Health Care
- ESE Telecommunications
- Exchange
- TOVX Nasdaq
- ESE Nasdaq
- Market Cap
- TOVX 4.7M
- ESE 3.4B
- IPO Year
- TOVX 2006
- ESE N/A
- Fundamental
- Price
- TOVX $1.34
- ESE $157.09
- Analyst Decision
- TOVX Strong Buy
- ESE Strong Buy
- Analyst Count
- TOVX 1
- ESE 2
- Target Price
- TOVX $6.00
- ESE $182.50
- AVG Volume (30 Days)
- TOVX 42.8K
- ESE 151.7K
- Earning Date
- TOVX 05-06-2025
- ESE 02-06-2025
- Dividend Yield
- TOVX N/A
- ESE 0.20%
- EPS Growth
- TOVX N/A
- ESE 18.29
- EPS
- TOVX N/A
- ESE 4.26
- Revenue
- TOVX N/A
- ESE $1,055,471,000.00
- Revenue This Year
- TOVX N/A
- ESE $12.30
- Revenue Next Year
- TOVX N/A
- ESE $16.05
- P/E Ratio
- TOVX N/A
- ESE $37.06
- Revenue Growth
- TOVX N/A
- ESE 8.94
- 52 Week Low
- TOVX $1.14
- ESE $97.11
- 52 Week High
- TOVX $17.00
- ESE $171.28
- Technical
- Relative Strength Index (RSI)
- TOVX 42.99
- ESE 51.10
- Support Level
- TOVX $1.28
- ESE $155.64
- Resistance Level
- TOVX $1.44
- ESE $160.69
- Average True Range (ATR)
- TOVX 0.09
- ESE 4.53
- MACD
- TOVX -0.02
- ESE -1.67
- Stochastic Oscillator
- TOVX 11.88
- ESE 9.24
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
About ESE ESCO Technologies Inc.
ESCO Technologies Inc sells engineered products and systems for utility, industrial, aerospace, and commercial applications. The firm operates in three segments: Aerospace and Defense, Utility Solutions Group (USG) and RF Shielding and Test (Test). The Aerospace and Defense segment designs and manufactures specialty filtration and naval products. The USG segment provides diagnostic testing solutions. The Test segment provides its customers with the ability to identify, measure and contain magnetic, electromagnetic and acoustic energy.